...
首页> 外文期刊>Tumour biology : >Applicability of gene expression profile of childhood acute lymphoblastic leukemia at diagnosis and at the end of the induction phase of chemotherapy at a cancer hospital in the state of Goiás (Brazil).
【24h】

Applicability of gene expression profile of childhood acute lymphoblastic leukemia at diagnosis and at the end of the induction phase of chemotherapy at a cancer hospital in the state of Goiás (Brazil).

机译:在戈亚斯州(巴西)的一家癌症医院,儿童急性淋巴细胞白血病的基因表达谱在诊断和化疗诱导阶段结束时的适用性。

获取原文
获取原文并翻译 | 示例
           

摘要

The present study compared the gene expression pattern of some previously described genes at the time of diagnosis and after induction chemotherapy for childhood acute lymphoblastic leukemia (ALL) in patients submitted to Brazilian Childhood Leukemia Treatment Group (GBTLI) ALL-99 Protocol. Samples were obtained at the time of diagnosis from 16 patients with ALL and on the 28th day of induction chemotherapy the bone marrow samples were obtained from 12 children. The genes expression profiles in diagnostic and induction samples were analyzed by array-based qPCR and then related to the clinical and biological prognostic factors. The results showed significant associations (p ≤ 0.05) between gender and immunophenotype, immunophenotype and age, immunophenotype and risk group, presence of CD10 and RUNX1 expression, risk group, and immunophenotype. A significant positive correlation was observed between the expression levels of BAX and BCL2. There was a significant difference (p = 0.008) between the gene expression pattern at the time of diagnosis and after induction chemotherapy. The expression pattern of these genes after the induction phase of treatment approached the expression profile of the control group, indicating a good induction response in children treated according to the GBTLI ALL-99 protocol. The findings of the current research could be routinely useful for clinical practice and could assist in the discovery phase of medical applications.
机译:本研究比较了提交巴西童年白血病治疗组(GBTLI)ALL-99协议的儿童在诊断时和诱导化疗后儿童急性淋巴细胞白血病(ALL)的某些先前描述的基因的基因表达模式。在诊断时从16例ALL患者中获取样本,在诱导化疗的第28天,从12例儿童中获取骨髓样本。通过基于阵列的qPCR分析诊断和诱导样品中的基因表达谱,然后与临床和生物学预后因素相关。结果显示性别与免疫表型,免疫表型与年龄,免疫表型与风险组,CD10和RUNX1表达的存在,风险组和免疫表型之间存在显着相关性(p≤0.05)。在BAX和BCL2的表达水平之间观察到显着的正相关。诊断时和诱导化疗后的基因表达模式之间存在显着差异(p = 0.008)。这些基因在诱导治疗后的表达模式接近对照组的表达谱,表明在按照GBTLI ALL-99方案治疗的儿童中有良好的诱导反应。当前研究的发现可能通常对临床实践有用,并且可以协助医学应用的发现阶段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号